Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reverse engineering of Alzheimer's disease based on biomarker pathways analysis.

Neurobiology of aging - 1 Sept 2014

Richens Joanna L, Morgan Kevin, O'Shea Paul

Abstract excerpt

Alzheimer's disease (AD) poses an increasingly profound problem to society, yet progress toward a genuine understanding of the disease remains worryingly slow. Perhaps, the most outstanding problem with the biology of AD is the question of its mechanistic origins, that is, it remains unclear wherein the molecular failures occur that underlie the disease. We demonstrate how molecular biomarkers could help define...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Biomarkers
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Nerve Growth Factor

Share to Platelet-Derived Growth Factor

Share to Receptors, Notch

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 24684789
DOI: 10.1016/j.neurobiolaging.2014.02.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reverse engineering of Alzheimer's disease based on biomarker pathways analysis.PMID 24684789Read ↗

Biomarkers for Alzheimer's disease.Semantic proximity Read ↗

An overview of the genes and biomarkers in Alzheimer's disease.Semantic proximity Read ↗

From proteomics to biomarker discovery in Alzheimer's diseaseSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Emerging Biomarkers for Early Detection of Alzheimer’s Disease: A Systematic ReviewSemantic proximity Read ↗

Biomarker Modeling of Alzheimer’s DiseaseSemantic proximity Read ↗

CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease.Semantic proximity Read ↗

Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer’s Disease: Clinical Molecular and Genetic Studies on Alzheimer’s DiseaseSemantic proximity Read ↗

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Semantic proximity Read ↗

New insights into atypical Alzheimer's disease in the era of biomarkersSemantic proximity Read ↗

Biomarkers in Sporadic and Familial Alzheimer’s DiseaseSemantic proximity Read ↗

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.